This study has been completed. The goal of the Phase I part of this clinical research study is to find the highest tolerable dose of a combination of dasatinib, cetuximab, and FOLFOX (5-fluorouracil [5-FU], leucovorin [LV], and Eloxatin [oxaliplatin]) that can be given to patients with metastatic colorectal cancer. The safety of these drugs in combination will also be studied.
Shingles is a painful, usually blistering skin rash typically found on one side of the body, wrapping around the trunk or waist. But it can appear anywhere from the head, arms, chest, abdomen or buttocks down to the feet.
Years later, the virus can become active, causing shingles. The first symptoms of shingles are unusual skin sensations. These include pain, itching and tingling. Other symptoms include confusion, fatigue, fever, headache, memory loss, an upset stomach and stomach pain. These symptoms generally occur one to five days before a painful rash appears on one side of the body or face. In most people, the rash develops on the torso and extends to the front and the back of the body. The rash forms very painful blisters that typically become scabs in seven to 10 days.